Literature DB >> 23360787

Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity.

Thibaut Sesia1, Brandon Bizup, Anthony A Grace.   

Abstract

Obsessive compulsive disorder (OCD) is a psychiatric condition defined by intrusive thoughts (obsessions) associated with compensatory and repetitive behaviour (compulsions). However, advancement in our understanding of this disorder has been hampered by the absence of effective animal models and correspondingly analysis of the physiological changes that may be present in these models. To address this, we have evaluated two current rodent models of OCD; repeated injection of dopamine D2 agonist quinpirole and repeated adolescent injection of the tricyclic agent clomipramine in combination with a behavioural paradigm designed to produce compulsive lever pressing. These results were then compared with their relative impact on the state of activity of the mesolimbic dopaminergic system using extracellular recoding of spontaneously active dopamine neurons in the ventral tegmental area (VTA). The clomipramine model failed to exacerbate compulsive lever pressing and VTA dopamine neurons in clomipramine-treated rats had mildly diminished bursting activity. In contrast, quinpirole-treated animals showed significant increases in compulsive lever pressing, which was concurrent with a substantial diminution of bursting activity of VTA dopamine neurons. Therefore, VTA dopamine activity correlated with the behavioural response in these models. Taken together, these data support the view that compulsive behaviours likely reflect, at least in part, a disruption of the dopaminergic system, more specifically by a decrease in baseline phasic dopamine signalling mediated by burst firing of dopamine neurons.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23360787      PMCID: PMC3674214          DOI: 10.1017/S146114571200154X

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  43 in total

1.  Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission.

Authors:  Stan B Floresco; Anthony R West; Brian Ash; Holly Moore; Anthony A Grace
Journal:  Nat Neurosci       Date:  2003-09       Impact factor: 24.884

2.  Excessive lever pressing following post-training signal attenuation in rats: a possible animal model of obsessive compulsive disorder?

Authors:  D Joel; A Avisar
Journal:  Behav Brain Res       Date:  2001-08-27       Impact factor: 3.332

3.  Enhancement of excessive lever-pressing after post-training signal attenuation in rats by repeated administration of the D1 antagonist SCH 23390 or the D2 agonist quinpirole, but not the D1 agonist SKF 38393 or the D2 antagonist haloperidol.

Authors:  D Joel; A Avisar; J Doljansky
Journal:  Behav Neurosci       Date:  2001-12       Impact factor: 1.912

4.  Dopamine transporter density of basal ganglia assessed with [123I]IPT SPET in obsessive-compulsive disorder.

Authors:  Chan-Hyung Kim; Min-Seong Koo; Keun-Ah Cheon; Young-Hoon Ryu; Jong-Doo Lee; Hong-Shick Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-09-25       Impact factor: 9.236

5.  Effects of quinpirole on operant conditioning: perseveration of behavioral components.

Authors:  Daniel D Kurylo
Journal:  Behav Brain Res       Date:  2004-11-05       Impact factor: 3.332

6.  Firing modes of midbrain dopamine cells in the freely moving rat.

Authors:  B I Hyland; J N J Reynolds; J Hay; C G Perk; R Miller
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

7.  Effects of quinpirole on behavioral extinction.

Authors:  Daniel D Kurylo; Sarah Tanguay
Journal:  Physiol Behav       Date:  2003-10

8.  Selective alleviation of compulsive lever-pressing in rats by D1, but not D2, blockade: possible implications for the involvement of D1 receptors in obsessive-compulsive disorder.

Authors:  Daphna Joel; Julia Doljansky
Journal:  Neuropsychopharmacology       Date:  2003-01       Impact factor: 7.853

9.  Differences in behavior and monoamine laterality following neonatal clomipramine treatment.

Authors:  Susan L Andersen; Nathalie L Dumont; Martin H Teicher
Journal:  Dev Psychobiol       Date:  2002-07       Impact factor: 3.038

10.  Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder.

Authors:  Damiaan Denys; Nic van der Wee; Joost Janssen; Femke De Geus; Herman G M Westenberg
Journal:  Biol Psychiatry       Date:  2004-05-15       Impact factor: 13.382

View more
  15 in total

1.  Separate mechanisms for development and performance of compulsive checking in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD).

Authors:  Mark C Tucci; Anna Dvorkin-Gheva; Renee Sharma; Leena Taji; Paul Cheon; John Peel; Ashley Kirk; Henry Szechtman
Journal:  Psychopharmacology (Berl)       Date:  2014-02-28       Impact factor: 4.530

2.  Chronic ethanol exposure increases inhibition of optically targeted phasic dopamine release in the nucleus accumbens core and medial shell ex vivo.

Authors:  James R Melchior; Sara R Jones
Journal:  Mol Cell Neurosci       Date:  2017-09-20       Impact factor: 4.314

3.  Catechol-O-Methyltransferase Gene Polymorphisms in Specific Obsessive-Compulsive Disorder Patients' Subgroups.

Authors:  Fernanda Brito Melo-Felippe; Juliana Braga de Salles Andrade; Isabele Gomes Giori; Tamiris Vieira-Fonseca; Leonardo Franklin Fontenelle; Fabiana Barzotti Kohlrausch
Journal:  J Mol Neurosci       Date:  2015-12-19       Impact factor: 3.444

4.  Gut Barrier Dysfunction and Type 2 Immunity: Implications for Compulsive Behavior.

Authors:  Christopher T Fields; Benoit Chassaing; Geert J de Vries
Journal:  Med Hypotheses       Date:  2022-02-14       Impact factor: 4.411

Review 5.  Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease.

Authors:  T Celeste Napier; Jean-Christophe Corvol; Anthony A Grace; Jamie D Roitman; James Rowe; Valerie Voon; Antonio P Strafella
Journal:  Mov Disord       Date:  2014-12-05       Impact factor: 10.338

6.  Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.

Authors:  Markus Dold; Martin Aigner; Rupert Lanzenberger; Siegfried Kasper
Journal:  Int J Neuropsychopharmacol       Date:  2015-05-04       Impact factor: 5.176

Review 7.  Dopaminergic control of cognitive flexibility in humans and animals.

Authors:  Marianne Klanker; Matthijs Feenstra; Damiaan Denys
Journal:  Front Neurosci       Date:  2013-11-05       Impact factor: 4.677

8.  Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats.

Authors:  Angélica P Escobar; Marcela P González; Rodrigo C Meza; Verónica Noches; Pablo Henny; Katia Gysling; Rodrigo A España; José A Fuentealba; María E Andrés
Journal:  Int J Neuropsychopharmacol       Date:  2017-08-01       Impact factor: 5.176

9.  Transgenerational evidence of increases in dopamine D2 receptor sensitivity in rodents: Impact on sensorimotor gating, the behavioral response to nicotine and BDNF.

Authors:  Wesley Drew Gill; Katherine C Burgess; Cynthia Vied; Russell W Brown
Journal:  J Psychopharmacol       Date:  2021-07-22       Impact factor: 4.562

Review 10.  From Thought to Action: How the Interplay Between Neuroscience and Phenomenology Changed Our Understanding of Obsessive-Compulsive Disorder.

Authors:  J Bernardo Barahona-Corrêa; Marta Camacho; Pedro Castro-Rodrigues; Rui Costa; Albino J Oliveira-Maia
Journal:  Front Psychol       Date:  2015-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.